Corvus Pharmaceuticals Inc (CRVS)
NASDAQ
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -30.489 | -47.388 | -44.073 | -46.238 | -7.087 | -44.353 | -46.492 | -47.506 |
Return on Equity (%) | -71.534 | -51.152 | -48.1 | -51.444 | -8.369 | -51.079 | -53.898 | -57.024 |
Return on Invested Capital (%) | -74.041 | -52.362 | -50.786 | -54.141 | -83.713 | -89.454 | -87.983 | -101.416 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 3.773 | 4.032 | 3.763 | 2.544 | 2.543 | 2.087 | 1.205 | 0.789 |
Earnings Per Share | -1.033 | -2.645 | -1.601 | -1.67 | -0.211 | -0.929 | -0.887 | -0.551 |
Cash Per Share | 0.143 | 2.144 | 1.337 | 0.184 | 0.58 | 1.363 | 0.283 | 0.257 |
Working Capital Per Share | 3.696 | 3.91 | 3.702 | 2.473 | 1.17 | 1.324 | 0.707 | 0.43 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -1.033 | -2.645 | -1.601 | -1.67 | -0.211 | -0.929 | -0.887 | -0.551 |
EBITDA Per Share | -1.033 | -2.645 | -1.601 | -1.67 | -0.211 | -0.929 | -0.887 | -0.551 |
Free Cash Flow Per Share | -0.988 | -2.673 | -1.617 | -1.695 | -0.231 | -0.939 | -0.889 | -0.554 |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 20.92M | 21.04M | 29.32M | 27.95M | 28.37M | 46.55M | 46.55M | N/A |
Year End December 30 2023 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | 46.55M | 46.55M | N/A | 48.9M | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 327.07M |
Price to Earnings Ratio | -11.89 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 25.46 |
Price to Book Ratio | 8.31 |
Dividend Yield | - |
Shares Outstanding | 64.26M |
Average Volume (1 week) | 4.14M |
Average Volume (1 Month) | 1.57M |
52 Week Change | 203.64% |
52 Week High | 10.00 |
52 Week Low | 1.30 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.